These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2177095)

  • 41. Nonsense mutation in open reading frame E2 of bovine papillomavirus DNA.
    DiMaio D
    J Virol; 1986 Feb; 57(2):475-80. PubMed ID: 3003380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins.
    Ashrafi GH; Tsirimonaki E; Marchetti B; O'Brien PM; Sibbet GJ; Andrew L; Campo MS
    Oncogene; 2002 Jan; 21(2):248-59. PubMed ID: 11803468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
    Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
    Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding of bovine papillomavirus type 4 E8 to ductin (16K proteolipid), down-regulation of gap junction intercellular communication and full cell transformation are independent events.
    Ashrafi GH; Pitts JD; Faccini A; McLean P; O'Brien V; Finbow ME; Campo S
    J Gen Virol; 2000 Mar; 81(Pt 3):689-94. PubMed ID: 10675405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumorigenicity of primary mouse fibroblasts transformed by bovine papillomavirus type 1.
    Mäntyjärvi R; Sarkkinen H; Parkkinen S; Laatikainen A; Ryhänen A; Syrjänen K
    Intervirology; 1988; 29(6):311-9. PubMed ID: 2852654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell transformation induced by bovine papillomavirus DNA as an assay for tumor promoters and chemopreventive agents.
    Tsang SS; Stich HF; Fujiki H
    Cancer Detect Prev; 1991; 15(5):423-7. PubMed ID: 1661204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The bovine papillomavirus E5 oncogene can cooperate with ras: identification of p21 amino acids critical for transformation by c-rasH but not v-rasH.
    Willumsen BM; Vass WC; Velu TJ; Papageorge AG; Schiller JT; Lowy DR
    Mol Cell Biol; 1991 Dec; 11(12):6026-33. PubMed ID: 1658623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The synergism between bovine papillomavirus type 4 and quercetin is dependent on the timing of exposure.
    Cairney M; Campo MS
    Carcinogenesis; 1995 Aug; 16(8):1997-2001. PubMed ID: 7634432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts.
    Faccini AM; Cairney M; Ashrafi GH; Finbow ME; Campo MS; Pitts JD
    J Virol; 1996 Dec; 70(12):9041-5. PubMed ID: 8971040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The bovine papillomavirus type 4 long control region contains an epithelial specific enhancer.
    Morgan IM; Grindlay GJ; Campo MS
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():23-27. PubMed ID: 9934679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transfection of lipoma cells with papilloma bovine virus subgenomic fragment.
    Haus O; Moisant M; Racine L; Zahnd JP; Padieu P; Turc-Carel C
    Cell Biol Int Rep; 1991 Jan; 15(1):67-74. PubMed ID: 1848483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes.
    Morrione A; DeAngelis T; Baserga R
    J Virol; 1995 Sep; 69(9):5300-3. PubMed ID: 7636972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA.
    Lowy DR; Dvoretzky I; Shober R; Law MF; Engel L; Howley PM
    Nature; 1980 Sep; 287(5777):72-4. PubMed ID: 6251381
    [No Abstract]   [Full Text] [Related]  

  • 54. Malignant transformation of a papilloma induced by bovine papillomavirus type 4 in the nude mouse renal capsule.
    Gaukroger J; Chandrachud L; Jarrett WF; McGarvie GE; Yeudall WA; McCaffery RE; Smith KT; Campo MS
    J Gen Virol; 1991 May; 72 ( Pt 5)():1165-8. PubMed ID: 1851817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergism between bovine papillomavirus type 4 and the flavonoid quercetin in cell transformation in vitro.
    Pennie WD; Campo MS
    Virology; 1992 Oct; 190(2):861-5. PubMed ID: 1325710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced production of hepatitis B surface antigen in NIH 3T3 mouse fibroblasts by using extrachromosomally replicating bovine papillomavirus vector.
    Wang Y; Stratowa C; Schaefer-Ridder M; Doehmer J; Hofschneider PH
    Mol Cell Biol; 1983 Jun; 3(6):1032-9. PubMed ID: 6308420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transforming activity of bovine and human papillomaviruses in cultured cells.
    DiMaio D
    Adv Cancer Res; 1991; 56():133-59. PubMed ID: 1851373
    [No Abstract]   [Full Text] [Related]  

  • 58. A quantitative in vitro focus assay for bovine papilloma virus.
    Dvoretzky I; Shober R; Chattopadhyay SK; Lowy DR
    Virology; 1980 Jun; 103(2):369-75. PubMed ID: 6247821
    [No Abstract]   [Full Text] [Related]  

  • 59. Anomalous transforming behavior of a bovine papillomavirus type 1 mutant with an upstream promoter mutation.
    Stewart AC; Burnett S
    J Virol; 1994 Jul; 68(7):4669-72. PubMed ID: 8207842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistence of bovine papillomavirus (pBPV-1) as an extrachromosomal element in tissues of microinjected Xenopus laevis.
    Etkin LD
    Nucleic Acids Res; 1991 Jan; 19(1):191-2. PubMed ID: 1849256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.